Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
Kivu Bioscience Inc.
Evopoint Biosciences Inc.
Travera Inc
Eli Lilly and Company
Nammi Therapeutics Inc
Beijing Biotech
Jazz Pharmaceuticals
Revolution Medicines, Inc.
Bayer
AstraZeneca
AstraZeneca
Eli Lilly and Company
Filamon LTD
Eli Lilly and Company
AstraZeneca
NeoImmuneTech
Hoffmann-La Roche
Psyence Australia Pty Ltd
ViroMissile, Inc.
A2 Biotherapeutics Inc.
AstraZeneca
Arvinas Inc.
A2 Biotherapeutics Inc.
Revolution Medicines, Inc.
Poseida Therapeutics, Inc.
MacroGenics
xCures
Daiichi Sankyo
SN BioScience
Cue Biopharma
EXoPERT
Adela, Inc
Natera, Inc.
Second Life Therapeutics
Eli Lilly and Company
Degron Therapeutics Co.
Merck Sharp & Dohme LLC
Alaunos Therapeutics
Nuvation Bio Inc.
Tempus AI
Massive Bio, Inc.
Incyte Corporation
GE Healthcare
Actym Therapeutics, Inc.
AVM Biotechnology Inc
Eli Lilly and Company
LigaChem Biosciences, Inc.
Exelixis
TCR2 Therapeutics